Becatecarin (Helsinn Healthcare)

Rewcastle, G.W.

Idrugs the Investigational Drugs Journal 8(10): 838-847

2005


ISSN/ISBN: 1369-7056
PMID: 16254805
Document Number: 592898
Helsinn Healthcare SA is developing becatecarin, a topoisomerase II inhibitor for the potential intravenous treatment of cancer.

Document emailed within 1 workday
Secure & encrypted payments